ARYC. Please review updates on their board. Volume is increasing along with a steady move up on share price. .003 Increasing volume............. This company is severely undervalued.
Arrayit Corporation and Avant Diagnostics, Inc. provide the market’s first large panel biomarker monitoring test for ovarian cancer (OVC). OvaDx® is advanced microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Avant will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.
Market Cap $2 million Shares Outstanding 696 million
Arrayit production team expands blood card manufacturing to 10,000 units per week to meet microarray research demand http:// arrayit.com/Products/Prote in_Microarrays/Blood_Card/blood_card.html …
Arrayit production team expands blood card manufacturing to 10,000 units per week to meet microarray research demand http:// arrayit.com/Products/Prote in_Microarrays/Blood_Card/blood_card.html …
Arrayit customers at Axo Science Lyon France use Arrayit microarray platform to ID bladder cancer prevention markers http:// arrayit.com/Publications/b ladder-cancer-prevention.pdf …
Arrayit reports microarray technology sale to top nanotechnology healthcare leader Sonanutech Davis CA http:// sonanutech.net
Arrayit reports microarray technology sale to world diagnostics leader Ventana Medical Sysytems Roche Tucson AZ http://www. ventana.com
Arrayit contact top Wells Fargo analyst Tim Evans explains revenue/earnings synergies in life science & diagnostics http:// arrayit.com/Wells-Fargo-16 1114.pdf …
Arrayit ships $35K proprietary microarray platform to leading European distributor Grupo Taper Mem Martins Portugal http://www. taper.es
Arrayit reports microarray technology sale to agricultural biotechnology leader Microgaia Biotech Murcia Spain http:// microgaia.eu
Arrayit reports $10K microarray technology sale to world proteomics leader CDI Laboratories located in Baltimore MD http:// cdi-lab.com
Arrayit featured in Global DNA Microarray Market Research Report 2016 with top molecular DX companies GE and Cepheid http://www. reportsnreports.com/reports/732130 -global-dna-microarray-market-research-report-2016.html …
Arrayit designs custom microarray technology platform for top wellness testing company located in the European Union http:// arrayit.com/Products/Micro array_Platforms/microarray_platforms.html …
Arrayit customers at the Korea Research Institute use the Arrayit microarray platform to publish biosensors advance http:// pubs.acs.org/doi/abs/10.102 1/acs.analchem.6b02071 …
Arrayit confirms site visit business development meeting with advanced genomics leader Genomic Vision Bagneux France http://www. genomicvision.com
Arrayit SpotBot® Extreme Microarray Spotter newsletter receives 3,265 hits on life sciences tools segment strength http:// arrayit.com/Products/Micro arrayers/Microarray_Spotter/microarray_spotter.html …
Arrayit reports $200,000 microarray platform inquiry from top life sciences leaders AH Diagnostics Aarhus Denmark http://www. ahdiagnostics.dk
Arrayit reports $34K microarray instrument sale to top European Union life sciences distributor European Biotech Network Dolembreux Belgium.
Arrayit equity research contact Tim Evans Wells Fargo illustrates 15-quarter strength of venture capital investing in biotechnology sector.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.